These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 30920625
1. The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar. Das VNR, Siddiqui NA, Pandey K, Lal CS, Sinha SK, Bimal S, Topno RK, Singh SK, Kumar S, Das P. Trans R Soc Trop Med Hyg; 2019 Jun 01; 113(6):332-340. PubMed ID: 30920625 [Abstract] [Full Text] [Related]
2. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M. Trop Med Int Health; 2012 Nov 01; 17(11):1345-8. PubMed ID: 22882665 [Abstract] [Full Text] [Related]
3. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R. PLoS Negl Trop Dis; 2010 Oct 05; 4(10):. PubMed ID: 20957193 [Abstract] [Full Text] [Related]
4. PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India. Ganguly S, Saha P, Chatterjee M, Roy S, Ghosh TK, Guha SK, Kundu PK, Bera DK, Basu N, Maji AK. PLoS Negl Trop Dis; 2015 Oct 05; 9(10):e0004138. PubMed ID: 26485704 [Abstract] [Full Text] [Related]
5. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India. Das VNR, Siddiqui NA, Bhunia GS, Pandey K, Sinha SK, Ansari MZ, Topno RK, Lal CS, Ranjan A, Singh VP, Das P. PLoS Negl Trop Dis; 2021 Aug 05; 15(8):e0009598. PubMed ID: 34428232 [Abstract] [Full Text] [Related]
9. Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh. Ghosh D, Sagar SK, Uddin MR, Rashid MU, Maruf S, Nath R, Islam MN, Aktaruzzaman MM, Sohel ANM, Banjara MR, Kroeger A, Aseffa A, Mondal D. Int J Infect Dis; 2024 Oct 05; 147():107213. PubMed ID: 39179149 [Abstract] [Full Text] [Related]
10. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. Ramesh V, Kaushal H, Mishra AK, Singh R, Salotra P. BMC Public Health; 2015 Oct 26; 15():1092. PubMed ID: 26503551 [Abstract] [Full Text] [Related]
11. Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India. Goyal V, Das VNR, Singh SN, Singh RS, Pandey K, Verma N, Hightower A, Rijal S, Das P, Alvar J, Bern C, Alves F. PLoS Negl Trop Dis; 2020 Jul 26; 14(7):e0008429. PubMed ID: 32687498 [Abstract] [Full Text] [Related]
14. Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal. Joshi AB, Banjara MR, Das ML, Ghale P, Pant KR, Parajuli N, Pyakurel UR, Dahal GR, Das CL, Kroeger A, Aseffa A. PLoS Negl Trop Dis; 2023 Feb 26; 17(2):e0011138. PubMed ID: 36758102 [Abstract] [Full Text] [Related]
20. Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India. Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M. Trop Med Int Health; 2012 Dec 28. PubMed ID: 23279744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]